NM_002863.5:c.244-34G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002863.5(PYGL):​c.244-34G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0192 in 1,552,696 control chromosomes in the GnomAD database, including 339 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 31 hom., cov: 33)
Exomes 𝑓: 0.019 ( 308 hom. )

Consequence

PYGL
NM_002863.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.148

Publications

2 publications found
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
  • glycogen storage disease VI
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 14-50937871-C-T is Benign according to our data. Variant chr14-50937871-C-T is described in ClinVar as Benign. ClinVar VariationId is 258842.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0221 (3358/152268) while in subpopulation AFR AF = 0.0366 (1519/41540). AF 95% confidence interval is 0.035. There are 31 homozygotes in GnomAd4. There are 1596 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 31 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002863.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGL
NM_002863.5
MANE Select
c.244-34G>A
intron
N/ANP_002854.3
PYGL
NM_001163940.2
c.244-2686G>A
intron
N/ANP_001157412.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PYGL
ENST00000216392.8
TSL:1 MANE Select
c.244-34G>A
intron
N/AENSP00000216392.7
PYGL
ENST00000532462.5
TSL:1
c.244-34G>A
intron
N/AENSP00000431657.1
PYGL
ENST00000530336.2
TSL:1
n.311-34G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0220
AC:
3354
AN:
152150
Hom.:
31
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0365
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.0173
Gnomad SAS
AF:
0.0164
Gnomad FIN
AF:
0.00942
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0182
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.0166
AC:
4123
AN:
248690
AF XY:
0.0164
show subpopulations
Gnomad AFR exome
AF:
0.0350
Gnomad AMR exome
AF:
0.0110
Gnomad ASJ exome
AF:
0.00757
Gnomad EAS exome
AF:
0.0132
Gnomad FIN exome
AF:
0.0117
Gnomad NFE exome
AF:
0.0174
Gnomad OTH exome
AF:
0.0176
GnomAD4 exome
AF:
0.0188
AC:
26380
AN:
1400428
Hom.:
308
Cov.:
25
AF XY:
0.0188
AC XY:
13172
AN XY:
700268
show subpopulations
African (AFR)
AF:
0.0366
AC:
1176
AN:
32156
American (AMR)
AF:
0.0116
AC:
518
AN:
44618
Ashkenazi Jewish (ASJ)
AF:
0.00752
AC:
194
AN:
25788
East Asian (EAS)
AF:
0.0247
AC:
975
AN:
39400
South Asian (SAS)
AF:
0.0174
AC:
1482
AN:
85046
European-Finnish (FIN)
AF:
0.0123
AC:
639
AN:
51748
Middle Eastern (MID)
AF:
0.0169
AC:
93
AN:
5518
European-Non Finnish (NFE)
AF:
0.0190
AC:
20055
AN:
1057752
Other (OTH)
AF:
0.0214
AC:
1248
AN:
58402
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1252
2505
3757
5010
6262
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0221
AC:
3358
AN:
152268
Hom.:
31
Cov.:
33
AF XY:
0.0214
AC XY:
1596
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0366
AC:
1519
AN:
41540
American (AMR)
AF:
0.0166
AC:
254
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00720
AC:
25
AN:
3470
East Asian (EAS)
AF:
0.0173
AC:
90
AN:
5188
South Asian (SAS)
AF:
0.0164
AC:
79
AN:
4820
European-Finnish (FIN)
AF:
0.00942
AC:
100
AN:
10612
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0182
AC:
1240
AN:
68020
Other (OTH)
AF:
0.0218
AC:
46
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
179
359
538
718
897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0205
Hom.:
61
Bravo
AF:
0.0226
Asia WGS
AF:
0.0170
AC:
58
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.85
DANN
Benign
0.29
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17123214; hg19: chr14-51404589; API